These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 39082294)
1. Loss of Cells in the Retinal Ganglion Cell Layer as an Early Indication of Neurodegeneration in Multiple Sclerosis. Shenoy N; Liu F; Narayanan SP J Integr Neurosci; 2024 Jul; 23(7):129. PubMed ID: 39082294 [TBL] [Abstract][Full Text] [Related]
2. Exploring experimental autoimmune optic neuritis using multimodal imaging. Manogaran P; Walker-Egger C; Samardzija M; Waschkies C; Grimm C; Rudin M; Schippling S Neuroimage; 2018 Jul; 175():327-339. PubMed ID: 29627590 [TBL] [Abstract][Full Text] [Related]
3. Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis. Cruz-Herranz A; Dietrich M; Hilla AM; Yiu HH; Levin MH; Hecker C; Issberner A; Hallenberger A; Cordano C; Lehmann-Horn K; Balk LJ; Aktas O; Ingwersen J; von Gall C; Hartung HP; Zamvil SS; Fischer D; Albrecht P; Green AJ J Neuroinflammation; 2019 Nov; 16(1):203. PubMed ID: 31684959 [TBL] [Abstract][Full Text] [Related]
5. NADH-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the EAE animal model of MS. Talla V; Yu H; Chou TH; Porciatti V; Chiodo V; Boye SL; Hauswirth WW; Lewin AS; Guy J Mol Ther; 2013 Oct; 21(10):1876-88. PubMed ID: 23752309 [TBL] [Abstract][Full Text] [Related]
6. Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation. Gharagozloo M; Smith MD; Jin J; Garton T; Taylor M; Chao A; Meyers K; Kornberg MD; Zack DJ; Ohayon J; Calabresi BA; Reich DS; Eberhart CG; Pardo CA; Kemper C; Whartenby KA; Calabresi PA Acta Neuropathol; 2021 Nov; 142(5):899-915. PubMed ID: 34487221 [TBL] [Abstract][Full Text] [Related]
7. Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis. Manogaran P; Samardzija M; Schad AN; Wicki CA; Walker-Egger C; Rudin M; Grimm C; Schippling S Acta Neuropathol Commun; 2019 Jul; 7(1):116. PubMed ID: 31315675 [TBL] [Abstract][Full Text] [Related]
8. Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model. Dietrich M; Helling N; Hilla A; Heskamp A; Issberner A; Hildebrandt T; Kohne Z; Küry P; Berndt C; Aktas O; Fischer D; Hartung HP; Albrecht P J Neuroinflammation; 2018 Mar; 15(1):71. PubMed ID: 29514678 [TBL] [Abstract][Full Text] [Related]
9. Sequential phases of RGC axonal and somatic injury in EAE mice examined using DTI and OCT. Nishioka C; Liang HF; Barsamian B; Sun SW Mult Scler Relat Disord; 2019 Jan; 27():315-323. PubMed ID: 30469023 [TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Syc SB; Saidha S; Newsome SD; Ratchford JN; Levy M; Ford E; Crainiceanu CM; Durbin MK; Oakley JD; Meyer SA; Frohman EM; Calabresi PA Brain; 2012 Feb; 135(Pt 2):521-33. PubMed ID: 22006982 [TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography as a biomarker of neurodegeneration in multiple sclerosis: A review. Alonso R; Gonzalez-Moron D; Garcea O Mult Scler Relat Disord; 2018 May; 22():77-82. PubMed ID: 29605802 [TBL] [Abstract][Full Text] [Related]
12. Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis. Jin J; Smith MD; Kersbergen CJ; Kam TI; Viswanathan M; Martin K; Dawson TM; Dawson VL; Zack DJ; Whartenby K; Calabresi PA Acta Neuropathol Commun; 2019 Jul; 7(1):125. PubMed ID: 31366377 [TBL] [Abstract][Full Text] [Related]
13. Progression of retinal ganglion cell loss in multiple sclerosis is associated with new lesions in the optic radiations. Klistorner A; Graham EC; Yiannikas C; Barnett M; Parratt J; Garrick R; Wang C; You Y; Graham SL Eur J Neurol; 2017 Nov; 24(11):1392-1398. PubMed ID: 28799222 [TBL] [Abstract][Full Text] [Related]
14. Optical coherence tomography monitoring and diagnosing retinal changes in multiple sclerosis. Mehmood A; Ali W; Song S; Din ZU; Guo RY; Shah W; Ilahi I; Yin B; Yan H; Zhang L; Khan M; Ali W; Zeb L; Safari H; Li B Brain Behav; 2021 Oct; 11(10):e2302. PubMed ID: 34520634 [TBL] [Abstract][Full Text] [Related]
15. Peripapillary retinal nerve fiber layer thickness measured by optical coherence tomography in different clinical subtypes of multiple sclerosis. Jankowska-Lech I; Wasyluk J; Palasik W; Terelak-Borys B; Grabska-Liberek I Mult Scler Relat Disord; 2019 Jan; 27():260-268. PubMed ID: 30423530 [TBL] [Abstract][Full Text] [Related]
16. Early diagnosis of multiple sclerosis by OCT analysis using Cohen's d method and a neural network as classifier. Garcia-Martin E; Ortiz M; Boquete L; Sánchez-Morla EM; Barea R; Cavaliere C; Vilades E; Orduna E; Rodrigo MJ Comput Biol Med; 2021 Feb; 129():104165. PubMed ID: 33302162 [TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis. Behbehani R; Abu Al-Hassan A; Al-Salahat A; Sriraman D; Oakley JD; Alroughani R PLoS One; 2017; 12(2):e0172120. PubMed ID: 28192539 [TBL] [Abstract][Full Text] [Related]
18. Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography. Garcia-Martin E; Polo V; Larrosa JM; Marques ML; Herrero R; Martin J; Ara JR; Fernandez J; Pablo LE Ophthalmology; 2014 Feb; 121(2):573-9. PubMed ID: 24268855 [TBL] [Abstract][Full Text] [Related]
19. Early reduction of retinal thickness predicts physical and cognitive disability in newly diagnosed multiple sclerosis patients: results from a cross-sectional study. Toscano S; Chisari CG; Biondi A; Patti F Neurol Sci; 2024 Nov; 45(11):5385-5394. PubMed ID: 38951431 [TBL] [Abstract][Full Text] [Related]
20. Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis. Palani CD; Fouda AY; Liu F; Xu Z; Mohamed E; Giri S; Smith SB; Caldwell RB; Narayanan SP Mol Neurobiol; 2019 Dec; 56(12):8589-8602. PubMed ID: 31280447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]